EHealth Free Cash Flow Per Share vs Capex To Revenue Analysis

EHTH Stock

USD 7.70 2.24 41.03%

EHealth financial indicator trend analysis is much more than just examining eHealth latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether eHealth is a good investment. Please check the relationship between EHealth Free Cash Flow Per Share and its Capex To Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

Free Cash Flow Per Share vs Capex To Revenue

Free Cash Flow Per Share vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of eHealth Free Cash Flow Per Share account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between EHealth's Free Cash Flow Per Share and Capex To Revenue is -0.36. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of eHealth, assuming nothing else is changed. The correlation between historical values of EHealth's Free Cash Flow Per Share and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of eHealth are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Free Cash Flow Per Share i.e., EHealth's Free Cash Flow Per Share and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.36

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from EHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into eHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.As of now, EHealth's Tax Provision is decreasing as compared to previous years. The EHealth's current Sales General And Administrative To Revenue is estimated to increase to 0.35, while Selling General Administrative is projected to decrease to under 46.8 M.

	2021	2022	2023	2024 (projected)
Gross Profit	536.2M	403.7M	451.1M	473.7M
Total Revenue	538.2M	405.4M	452.9M	475.5M

Gross Profit Total Revenue

EHealth fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		1.0	0.43	0.81	0.74	0.9	0.92	0.81	0.74	0.67	0.78	0.5	0.53	0.53	0.22	1.0	0.93	0.42	0.76	0.72	0.87	0.69	0.9	0.98	-0.17	0.56
Total Stockholder Equity	1.0		0.41	0.8	0.77	0.92	0.88	0.78	0.71	0.64	0.77	0.53	0.47	0.51	0.28	0.99	0.94	0.48	0.75	0.74	0.83	0.73	0.89	0.99	-0.12	0.56
Retained Earnings	0.43	0.41		0.69	0.51	0.12	0.47	0.58	0.72	0.9	0.68	0.22	0.45	0.77	-0.37	0.46	0.17	-0.17	-0.04	0.47	0.34	0.38	0.55	0.34	-0.5	-0.15
Other Assets	0.81	0.8	0.69		0.65	0.62	0.75	0.66	0.76	0.77	0.89	0.72	0.5	0.66	0.02	0.81	0.68	0.25	0.24	0.61	0.71	0.77	0.81	0.76	-0.28	0.22
Common Stock Shares Outstanding	0.74	0.77	0.51	0.65		0.65	0.54	0.59	0.73	0.59	0.69	0.4	0.09	0.52	0.47	0.72	0.63	0.6	0.44	0.96	0.39	0.63	0.7	0.79	0.14	0.51
Other Stockholder Equity	0.9	0.92	0.12	0.62	0.65		0.7	0.5	0.42	0.37	0.57	0.49	0.27	0.32	0.46	0.86	0.98	0.65	0.76	0.63	0.72	0.74	0.73	0.94	0.08	0.6
Total Liab	0.92	0.88	0.47	0.75	0.54	0.7		0.91	0.8	0.74	0.76	0.31	0.78	0.58	-0.08	0.94	0.78	0.08	0.72	0.54	0.96	0.46	0.87	0.82	-0.38	0.5
Other Current Liab	0.81	0.78	0.58	0.66	0.59	0.5	0.91		0.86	0.81	0.67	0.28	0.71	0.51	-0.15	0.84	0.58	-0.04	0.66	0.6	0.8	0.32	0.77	0.72	-0.45	0.43
Total Current Liabilities	0.74	0.71	0.72	0.76	0.73	0.42	0.8	0.86		0.84	0.88	0.32	0.62	0.76	-0.12	0.77	0.51	0.04	0.4	0.74	0.64	0.47	0.85	0.64	-0.22	0.26
Other Liab	0.67	0.64	0.9	0.77	0.59	0.37	0.74	0.81	0.84		0.73	0.27	0.67	0.7	-0.33	0.7	0.43	-0.13	0.3	0.6	0.64	0.43	0.68	0.57	-0.57	0.12
Property Plant And Equipment Net	0.78	0.77	0.68	0.89	0.69	0.57	0.76	0.67	0.88	0.73		0.51	0.51	0.87	-0.02	0.8	0.66	0.24	0.31	0.64	0.64	0.75	0.94	0.71	-0.11	0.12
Current Deferred Revenue	0.5	0.53	0.22	0.72	0.4	0.49	0.31	0.28	0.32	0.27	0.51		0.05	0.1	0.27	0.48	0.52	0.42	0.04	0.37	0.31	0.76	0.42	0.55	0.01	0.05
Net Debt	0.53	0.47	0.45	0.5	0.09	0.27	0.78	0.71	0.62	0.67	0.51	0.05		0.48	-0.64	0.6	0.4	-0.51	0.45	0.2	0.77	0.1	0.57	0.35	-0.49	0.17
Accounts Payable	0.53	0.51	0.77	0.66	0.52	0.32	0.58	0.51	0.76	0.7	0.87	0.1	0.48		-0.23	0.57	0.39	0.03	0.13	0.45	0.45	0.5	0.79	0.43	-0.17	-0.06
Cash	0.22	0.28	-0.37	0.02	0.47	0.46	-0.08	-0.15	-0.12	-0.33	-0.02	0.27	-0.64	-0.23		0.14	0.34	0.94	0.22	0.36	-0.06	0.31	0.04	0.4	0.5	0.51
Non Current Assets Total	1.0	0.99	0.46	0.81	0.72	0.86	0.94	0.84	0.77	0.7	0.8	0.48	0.6	0.57	0.14		0.91	0.34	0.76	0.71	0.89	0.67	0.92	0.95	-0.21	0.54
Non Currrent Assets Other	0.93	0.94	0.17	0.68	0.63	0.98	0.78	0.58	0.51	0.43	0.66	0.52	0.4	0.39	0.34	0.91		0.55	0.77	0.62	0.79	0.76	0.81	0.94	0.03	0.54
Cash And Short Term Investments	0.42	0.48	-0.17	0.25	0.6	0.65	0.08	-0.04	0.04	-0.13	0.24	0.42	-0.51	0.03	0.94	0.34	0.55		0.29	0.48	0.08	0.59	0.29	0.59	0.47	0.43
Net Receivables	0.76	0.75	-0.04	0.24	0.44	0.76	0.72	0.66	0.4	0.3	0.31	0.04	0.45	0.13	0.22	0.76	0.77	0.29		0.48	0.72	0.26	0.59	0.75	-0.06	0.65
Common Stock Total Equity	0.72	0.74	0.47	0.61	0.96	0.63	0.54	0.6	0.74	0.6	0.64	0.37	0.2	0.45	0.36	0.71	0.62	0.48	0.48		0.4	0.54	0.66	0.75	0.17	0.53
Non Current Liabilities Total	0.87	0.83	0.34	0.71	0.39	0.72	0.96	0.8	0.64	0.64	0.64	0.31	0.77	0.45	-0.06	0.89	0.79	0.08	0.72	0.4		0.43	0.77	0.78	-0.44	0.52
Other Current Assets	0.69	0.73	0.38	0.77	0.63	0.74	0.46	0.32	0.47	0.43	0.75	0.76	0.1	0.5	0.31	0.67	0.76	0.59	0.26	0.54	0.43		0.71	0.74	0.09	0.05
Property Plant And Equipment Gross	0.9	0.89	0.55	0.81	0.7	0.73	0.87	0.77	0.85	0.68	0.94	0.42	0.57	0.79	0.04	0.92	0.81	0.29	0.59	0.66	0.77	0.71		0.84	-0.09	0.3
Total Current Assets	0.98	0.99	0.34	0.76	0.79	0.94	0.82	0.72	0.64	0.57	0.71	0.55	0.35	0.43	0.4	0.95	0.94	0.59	0.75	0.75	0.78	0.74	0.84		-0.07	0.6
Short Term Debt	-0.17	-0.12	-0.5	-0.28	0.14	0.08	-0.38	-0.45	-0.22	-0.57	-0.11	0.01	-0.49	-0.17	0.5	-0.21	0.03	0.47	-0.06	0.17	-0.44	0.09	-0.09	-0.07		0.14
Intangible Assets	0.56	0.56	-0.15	0.22	0.51	0.6	0.5	0.43	0.26	0.12	0.12	0.05	0.17	-0.06	0.51	0.54	0.54	0.43	0.65	0.53	0.52	0.05	0.3	0.6	0.14

Click cells to compare fundamentals

EHealth Account Relationship Matchups

EHealth fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	741.6M	1.0B	1.1B	1.1B	1.1B	1.2B
Total Stockholder Equity	527.2M	837.6M	982.1M	914.2M	904.1M	949.3M
Retained Earnings	271.9M	316.2M	193.2M	73.8M	7.3M	6.9M
Other Assets	421.3M	603.1M	690.3M	648.2M	202.9M	147.4M
Common Stock Shares Outstanding	24.5M	27.0M	26.8M	27.4M	28.0M	21.4M
Liabilities And Stockholders Equity	741.6M	1.0B	1.1B	1.1B	1.1B	1.2B
Other Stockholder Equity	(16.7M)	521.0M	555.9M	577.2M	598.8M	628.7M
Total Liab	214.5M	202.5M	167.2M	198.4M	209.3M	219.7M
Other Current Liab	81.1M	36.8M	50.6M	40.9M	57.2M	60.1M
Total Current Liabilities	113.0M	84.4M	75.5M	60.6M	78.5M	40.2M
Other Liab	67.2M	76.7M	55.9M	37.5M	43.1M	22.7M
Property Plant And Equipment Net	47.1M	57.2M	49.5M	32.0M	27.6M	16.2M
Current Deferred Revenue	2.6M	308K	52.8M	32.4M	(127K)	(120.7K)
Net Debt	15.6M	2.8M	(40.6M)	(37.6M)	(12.6M)	(13.2M)
Accounts Payable	24.6M	36.9M	13.8M	6.7M	7.2M	7.6M
Cash	23.5M	43.8M	81.9M	144.4M	115.7M	85.4M
Non Current Assets Total	533.5M	709.0M	741.7M	711.5M	731.0M	767.5M
Non Currrent Assets Other	21.4M	603.1M	690.3M	612.6M	679.8M	713.8M
Cash And Short Term Investments	23.5M	93.4M	123.2M	144.4M	121.7M	97.3M
Net Receivables	176.9M	221.0M	260.6M	245.4M	922.2M	968.3M
Common Stock Total Equity	35K	38K	39K	40K	46K	29.8K
Non Current Liabilities Total	101.5M	118.1M	91.7M	137.8M	130.7M	137.3M
Other Current Assets	2.4M	16.7M	23.8M	11.3M	8.6M	6.1M
Property Plant And Equipment Gross	47.1M	57.2M	49.5M	32.0M	38.8M	40.7M
Total Current Assets	208.1M	331.0M	407.6M	401.1M	382.4M	401.5M
Accumulated Other Comprehensive Income	116K	350K	390K	(73K)	(82K)	(77.9K)
Short Term Debt	4.8M	10.4M	11.1M	13.0M	14.1M	11.2M
Intangible Assets	10.1M	8.6M	1.9M	31.3M	23.6M	24.8M
Common Stock	35K	38K	39K	40K	41K	30.5K
Property Plant Equipment	10.5M	14.6M	49.5M	5.5M	6.3M	9.4M
Short Long Term Debt Total	39.1M	46.6M	41.4M	106.8M	103.2M	53.8M
Inventory	5.5M	16.1M	22.9M	1.0	0.9	0.86
Net Tangible Assets	511.2M	830.1M	747.6M	914.2M	1.1B	1.1B
Retained Earnings Total Equity	271.9M	316.2M	193.2M	73.8M	84.9M	101.3M
Capital Surpluse	455.2M	721.0M	755.9M	777.2M	893.8M	472.6M
Deferred Long Term Liab	64.1M	72.3M	50.8M	32.4M	37.2M	26.0M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:

How To Invest In EHealth

Details

Is EHealth Stock a good investment?

Details

What is EHealth's Net Worth?

Details

Largest Insurance Brokers Companies

View

Largest Financial Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.108

Earnings Share

(2.62)

Revenue Per Share

16.016

Quarterly Revenue Growth

(0.1)

Return On Assets

(0.01)

The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EHealth Free Cash Flow Per Share vs Capex To Revenue Analysis

Free Cash Flow Per Share vs Capex To Revenue

Free Cash Flow Per Share vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Free Cash Flow Per Share

Capex To Revenue

EHealth fundamental ratios Correlations

EHealth Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EHealth fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Non Current Assets Total	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.98	Total Assets
Non Currrent Assets Other	+ 0.98	Other Stockholder Equity

Cash	- 0.64	Net Debt
Short Term Debt	- 0.57	Other Liab
Cash And Short Term Investments	- 0.51	Net Debt
Short Term Debt	- 0.5	Retained Earnings
Short Term Debt	- 0.49	Net Debt
Short Term Debt	- 0.45	Other Current Liab